A short history of sulfa drugs

Sulfa drugs were the first effective broad-spectrum antibacterials. Gerhard Domagk at Bayer demonstrated the activity of Prontosil in the early 1930s, an achievement recognised with the Nobel Prize in Physiology or Medicine in 1939. A separate disaster — the 1937 Elixir Sulfanilamide poisoning in the United States — killed more than a hundred people and led directly to the 1938 Federal Food, Drug, and Cosmetic Act, the foundation of modern American drug regulation.

Before sulfa

For most of medical history, bacterial infection was treated with whatever happened to be at hand: antiseptics on wounds, supportive care, the patient's own immune system. Bacterial pneumonia, puerperal sepsis after childbirth, and streptococcal skin infections were common causes of death. There was no specific cure. Salvarsan, an arsenical introduced for syphilis early in the 20th century, was the closest thing to a directed antibacterial — narrow, toxic, and limited in scope.

Prontosil

In the 1930s, Gerhard Domagk and colleagues at the dye manufacturer Bayer screened hundreds of azo compounds for antibacterial activity in mice. Prontosil — a brick-red dye — proved to cure streptococcal infections in animal models that had been uniformly fatal. The work was published in 1935. Within a few years it had transformed the treatment of streptococcal sepsis worldwide.

French researchers at the Pasteur Institute soon showed something curious: Prontosil only worked in the body, not in a test tube. The active agent was not the dye itself but a metabolite, sulfanilamide, released after the body cleaved the azo bond. Sulfanilamide was already a known compound, unpatented, and could be made cheaply. Within months, generic sulfanilamide preparations were everywhere — a development that broke the commercial monopoly Bayer had assumed but accelerated the spread of the cure. The mechanism — competitive inhibition of bacterial folate synthesis — would not be understood until the 1940s. How sulfa drugs work covers the science.

The Nobel Prize

The Nobel Committee awarded Domagk the Prize in Physiology or Medicine in 1939. Nazi Germany had forbidden German citizens from accepting Nobel Prizes following an earlier political dispute over the Peace Prize, and Domagk was briefly arrested when he attempted to communicate his acceptance. He received the medal and diploma after the war, in 1947. The cash had by then reverted to the Nobel Foundation and was not paid.

Wartime use and the antibiotic era

Sulfonamide powders were carried in the field kits of soldiers in the Second World War, where they reduced wound infection. The drugs treated streptococcal pneumonia, meningitis, and a wide range of skin and soft-tissue infections. They had real limits — toxicity, narrow efficacy in some bacterial species, and the rapid emergence of resistance — but they were the first chemical agents to make routine bacterial illness reliably curable. Penicillin became widely available later in the 1940s and gradually displaced sulfonamides for many indications, but the sulfa drugs were the prototype that proved the antibiotic concept.

The 1937 Elixir Sulfanilamide disaster

In 1937 the S. E. Massengill Company in Tennessee sold a liquid preparation of sulfanilamide flavoured with raspberry, intended for children who could not swallow tablets. The solvent was diethylene glycol, an industrial liquid that the manufacturer's chemists assumed would be safe because it had a sweet taste. Diethylene glycol is severely nephrotoxic. More than 100 people died, many of them children. The episode is among the worst mass medication poisonings in U.S. history.

The Massengill product had been sold legally. Under the law of the time, the U.S. Food and Drug Administration could only act against a misbranded product, not an unsafe one — and the elixir was not misbranded under the narrow legal definition. Public outrage forced legislative reform. In 1938 Congress passed the Federal Food, Drug, and Cosmetic Act, which for the first time required that new drugs be shown to be safe before sale. The mechanism that today reviews every new prescription medicine in the United States traces directly to this episode.

Diethylene glycol poisoning still happens. Counterfeit medicines and improperly compounded liquid preparations have caused diethylene glycol mass poisonings in several countries since 1937, most recently in the 21st century. The mechanism that killed in 1937 has not been retired by chemistry alone — it has been retired only by regulation, where regulation holds.

The modern era

Sulfa drugs no longer dominate antibacterial therapy. Resistance, the rise of penicillins and cephalosporins, and a better understanding of allergy have pushed them to specific roles — uncomplicated urinary tract infection, Pneumocystis jirovecii pneumonia prophylaxis and treatment, Stenotrophomonas infections, and others described on the sulfa antibiotics page. The non-antibiotic sulfonamides — furosemide, HCTZ, celecoxib, sulfonylureas, acetazolamide — emerged later as separate stories, sharing only the chemical group with the original sulfanilamide.

The historical assumption that any "sulfa allergy" precluded all sulfonamides was a product of the era when the antibiotics dominated and the chemistry was less well understood. Modern cross-reactivity data support a more limited reading.